These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31665722)

  • 1. Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study.
    Wang P; Qiang H; Song Y; Dang Y; Luan H; Cao L; Cui Q; Tian G
    Cardiology; 2019; 144(3-4):90-96. PubMed ID: 31665722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
    Dogan S; Celikbilek M; Yilmaz YK; Sarikaya S; Zararsiz G; Serin HI; Borekci E; Akyol L; Pirti I; Davarci SE
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):298-304. PubMed ID: 25629574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease.
    Lee SH; Yun SJ; Kim DH; Jo HH; Park YS
    J Clin Ultrasound; 2017 Sep; 45(7):391-399. PubMed ID: 28369989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
    Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease.
    Luo K; Bian J; Wang Q; Wang J; Chen F; Li H; Jin D
    Turk J Gastroenterol; 2019 Jul; 30(7):611-615. PubMed ID: 31290748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of characteristics between nonobese and overweight/obese subjects with nonalcoholic fatty liver disease in a South Indian population.
    Vendhan R; Amutha A; Anjana RM; Unnikrishnan R; Deepa M; Mohan V
    Diabetes Technol Ther; 2014 Jan; 16(1):48-55. PubMed ID: 24028151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.
    Zhao J; Fan H; Wang T; Yu B; Mao S; Wang X; Zhang W; Wang L; Zhang Y; Ren Z; Liang B
    Cardiovasc Diabetol; 2022 Jul; 21(1):123. PubMed ID: 35778734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.
    Leung JC; Loong TC; Wei JL; Wong GL; Chan AW; Choi PC; Shu SS; Chim AM; Chan HL; Wong VW
    Hepatology; 2017 Jan; 65(1):54-64. PubMed ID: 27339817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study.
    Park HE; Kwak MS; Kim D; Kim MK; Cha MJ; Choi SY
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3134-43. PubMed ID: 27253666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation.
    Chen LZ; Jing XB; Wu CF; Zeng YC; Xie YC; Wang MQ; Chen WX; Hu X; Zhou YN; Cai XB
    Dis Markers; 2021; 2021():6591784. PubMed ID: 34992694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography.
    Langroudi TF; Haybar H; Parsa SA; Mahjoorian M; Khaheshi I; Naderian M
    Rom J Intern Med; 2018 Sep; 56(3):167-172. PubMed ID: 29561732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.
    Idilman IS; Akata D; Hazirolan T; Doganay Erdogan B; Aytemir K; Karcaaltincaba M
    J Diabetes; 2015 Mar; 7(2):279-86. PubMed ID: 24893617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
    Jacobs K; Brouha S; Bettencourt R; Barrett-Connor E; Sirlin C; Loomba R
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1337-1344.e3. PubMed ID: 26820400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study.
    Wu R; Hou F; Wang X; Zhou Y; Sun K; Wang Y; Liu H; Wu J; Zhao R; Hu J
    Sci Rep; 2017 Aug; 7(1):9933. PubMed ID: 28855585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study.
    Kim HJ; Kim JH; Choe WH; Kwon SY; Lee CH
    Clin Mol Hepatol; 2014 Jun; 20(2):154-61. PubMed ID: 25032181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity.
    Kim SH; Park HY; Lee HS; Jung KS; Lee MH; Jhee JH; Kim TH; Lee JE; Kim HJ; Kim BS; Park HC; Lee BK; Choi HY
    Sci Rep; 2020 Jan; 10(1):1025. PubMed ID: 31974458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease.
    Zhang Y; Xu J; Wang X; Ren X; Liu Y
    BMC Genomics; 2019 Nov; 20(1):862. PubMed ID: 31726978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.